Outcomes of simultaneous kidney - Pancreas transplantation in African-American recipients: A case-control study

Clinical Transplantation

Volumn 14, Issue 6, 2000, Pages 572-579

  Lo, Agnes ^a   Stratta, Robert J ^a   Francesca Egidi, M ^a   Hosein Shokouh Amiri, M ^a   Grewal, Hani P ^a   Tarik Kizilisik, A ^a   Allowaya, Rita R ^a   Gaber, Lillian W ^a   Osama Gaber, A ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

African American; Case control; Mycophenolate mofetil; Pancreas transplantation; Racial differences; Rejection; Simultaneous kidney; Tacrolimus

Indexed keywords

AMYLASE; C PEPTIDE; COTRIMOXAZOLE; CYTOMEGALOVIRUS ANTIBODY; FLUCONAZOLE; GANCICLOVIR; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTAMIDINE; PREDNISONE; SULFANILAMIDE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE DISEASE; ADULT; ALLOTRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LAPAROTOMY; MALE; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS BIOPSY; PANCREAS FUNCTION; PANCREAS TRANSPLANTATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REOPERATION; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AFRICAN AMERICANS; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LENGTH OF STAY; MALE; PANCREAS TRANSPLANTATION; RISK FACTORS; TREATMENT OUTCOME;

EID: 0033672220     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2000.140610.x     Document Type: Article

References (15)

1. Pancreas transplantation for diabetes mellitus
2. Analysis of pancreas transplant outcomes for United States cases reported to the United Network for Organ Sharing (UNOS) and the non-US cases reported to the International Pancreas Transplant Registry (IPTR)
3. Racial disparities in renal transplant outcomes
4. Influence of race of cadaveric kidney donor and recipient on graft survival: A multifactorial analysis
5. The effect of patient's preferences on racial differences in access to renal transplantation
6. Effect of race on outcome following kidney and kidney-pancreas transplantation in type 1 diabetics: The south-eastern organ procurement foundation experience
7. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine
8. Racial variation in dosage requirements of tacrolimus
9. Methylprednisolone pharmacokinetics, cortisol response, and adverse effects in black and white renal transplant recipients
10. African-Americans with type 1 insulin-dependent diabetes mellitus and end stage renal disease: Results after simultaneous pancreas kidney transplantation
11. African-American patients with renal failure secondary to diabetes should be referred for combined kidney-pancreas transplant
12. Successful long-term kidney-pancreas transplants in diabetic patients with high C-peptide levels
13. Immunosuppressive therapy in high-risk transplant patients: Dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients
14. Mycophenolate mofetil reduces the risk of acute rejection less in African-American than in Caucasian kidney recipients
15. Isolated pancreas rejection in combined kidney pancreas transplantation